Comparative Study Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients Undergoing Breast Surgery
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Palonosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 25 Aug 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 25 Aug 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018.
- 24 Oct 2016 New trial record